Tremor laryngeal dystonia: Treatment of the lateral cricoarytenoid muscle

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 5 I, 2004, Pages 349-355

  Maronian, Nicole C ^a,b   Waugh, Patricia F ^a,b   Robinson, Lawrence ^a,b   Hillel, Allen D ^a,b  

^a Univ of Washington Medical Center ^*

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Botulinum toxin; Electromyography; Laryngeal dystonia; Lateral cricoarytenoid muscle; Spasmodic dysphonia; Tremor; Voice quality

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CRICOARYTENOID MUSCLE; DYSPHONIA; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LARYNX MUSCLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROBOSCOPY; THYROARYTENOID MUSCLE; TREATMENT OUTCOME; TREMOR LARYNGEAL DYSTONIA; VOICE;

EID: 2442626540     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300502     Document Type: Article

References (17)

1. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100: 85-9.
2. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998; 108:1435-41.
3. Koufman JA. Classification of laryngeal dystonias. In: Koufman JA, ed. The visible voice. Winston-Salem, NC: The Center for Voice Disorders of Wake Forest University, 1992; 1(July):1-22.
4. Woodson GE, Zwirner P, Murry T, Swenson M. The use of flexible fiberoptic laryngoscopy to assess patients with spasmodic dysphonia. J Voice 1991;5:85-91.
5. Aronson AE, McCaffrey TV, Litchy WJ, Lipton RJ. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections. Laryngoscope 1993;103:683-92.
6. Warrick P, Dromey C, Irish J, Durkin L. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice 2000;14:410-21.
7. Warrick P, Dromey C, Irish JC, Durkin L, Pakiam A, Lang A. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope 2000;110: 1366-74.
8. Hertegard S, Granqvist S, Lindestad PA. Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol 2000;109:204-9.
9. Koda J, Ludlow CL. An evaluation of laryngeal muscle activation in patients with voice tremor. Otolaryngol Head Neck Surg 1992;107:684-96.
10. Aronson AE, Hartman DE. Adductor spastic dysphonia as a sign of essential (voice) tremor. J Speech Hear Disord 1981; 46:52-8.
11. Hillel AD. The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple fine-wire electromyography. Laryngoscope 2001; 111(suppl 97).
12. Klotz DA, Maronian NC, Waugh PF, Shahinfar A, Robinson L, Hillel AD. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography. Ann Otol Rhinol Laryngol (in press).
13. Hirano M, Ohala J. Use of hooked-wire electrodes for electromyography of the intrinsic laryngeal muscles. J Speech Hear Res 1969;12:362-73.
14. Cannito MP, Burch AR, Watts C, Rappold PW, Hood SB, Sherrard K. Disfluency in spasmodic dysphonia: a multivariate analysis. J Speech Lang Hear Res 1997;40:627-41.
15. Inagi K, Ford CN, Bless DM, Heisey D. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia. J Voice 1996;10:306-13.
16. Tomoda H, Shibasaki H, Kuroda Y, Shin T. Voice tremor: dysregulation of voluntary expiratory muscles. Neurology 1987; 37:117-22.
17. Ludlow CL, Naunton RF, Bassich CJ. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section. Otolaryngol Head Neck Surg 1984;92:24-31.